PTC Therapeutics
PTCT
#3123
Rank
โ‚น314.10 B
Marketcap
โ‚น3,983
Share price
-3.39%
Change (1 day)
68.25%
Change (1 year)

Revenue for PTC Therapeutics (PTCT)

Revenue in 2024 (TTM): โ‚น67.84 Billion

According to PTC Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚น68.75 Billion. a decrease over the revenue in the year 2023 that were of โ‚น78.07 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for PTC Therapeutics from 2012 to 2024

Annual revenue

Year Revenue Change
2024 โ‚น69.21 B-11.35%
2023 โ‚น78.07 B35.01%
2022 โ‚น57.82 B44.25%
2021 โ‚น40.08 B43.96%
2020 โ‚น27.84 B27.21%
2019 โ‚น21.89 B18.26%
2018 โ‚น18.51 B49.14%
2017 โ‚น12.41 B120.85%
2016 โ‚น5.62 B115.47%
2015 โ‚น2.60 B79.21%
2014 โ‚น1.45 B-24.8%
2013 โ‚น1.93 B22.82%
2012 โ‚น1.57 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น939.21 B 1,265.94%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น162.09 B 135.75%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.16 B-98.31%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น0.92 B-98.65%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น10.88 B-84.17%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.408 T 6,310.92%๐Ÿ‡จ๐Ÿ‡ญ Switzerland